Bionomics Limited Short Interest Update
| BNOX Stock | USD 0.28 0.02 6.67% |
Slightly above 62% of Bionomics' investor base is looking to short. The analysis of the overall investor sentiment regarding Bionomics Ltd ADR suggests that many traders are alarmed. Bionomics' investing sentiment can be driven by a variety of factors including economic data, Bionomics' earnings reports, geopolitical events, and overall market trends.
Bionomics |
Bionomics Limited saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 13,800 shares, a decrease of 81.1 percent from the September 30th total of 73,000 shares. Based on an average daily trading volume, of 626,600 shares, the short-interest ratio
Read at thelincolnianonline.com
 |
Bionomics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Bionomics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bionomics Fundamental Analysis
We analyze Bionomics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Bionomics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Bionomics ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bionomics stock to make a market-neutral strategy. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics with similar companies.
Peers
Bionomics Related Equities
| SPRC | Scisparc | 20.83 | ||||
| ADAG | Adagene | 8.13 | ||||
| ACUT | Accustem Sciences | 3.23 | ||||
| PMVP | Pmv Pharmaceuticals | 2.55 | ||||
| ACRV | Acrivon Therapeutics, | 0.92 | ||||
| ANEB | Anebulo Pharmaceuticals | 1.32 | ||||
| AVTE | Aerovate Therapeutics | 1.88 | ||||
| RZLT | Rezolute | 2.99 | ||||
| ANTX | AN2 Therapeutics | 5.38 |
Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.